Pharmacological rescue of cognitive function in a mouse model of chemobrain
After chemotherapy, many cancer survivors suffer from long-lasting cognitive impairment, colloquially known as “chemobrain.” However, the trajectories of cognitive changes and the underlying mechanisms remain unclear. We previously established paclitaxel-induced inositol trisphosphate receptor (InsP...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 June 2021
|
| In: |
Molecular neurodegeneration
Year: 2021, Volume: 16, Pages: 1-16 |
| ISSN: | 1750-1326 |
| DOI: | 10.1186/s13024-021-00463-2 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13024-021-00463-2
|
| Author Notes: | Lien D. Nguyen, Tom T. Fischer and Barbara E. Ehrlich |
| Summary: | After chemotherapy, many cancer survivors suffer from long-lasting cognitive impairment, colloquially known as “chemobrain.” However, the trajectories of cognitive changes and the underlying mechanisms remain unclear. We previously established paclitaxel-induced inositol trisphosphate receptor (InsP3R)-dependent calcium oscillations as a mechanism for peripheral neuropathy, which was prevented by lithium pretreatment. Here, we investigated if a similar mechanism also underlay paclitaxel-induced chemobrain. |
|---|---|
| Item Description: | Gesehen am 11.08.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1750-1326 |
| DOI: | 10.1186/s13024-021-00463-2 |